Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2020 Oct 1;27(10):1108-1122.
doi: 10.5551/jat.54130. Epub 2020 Apr 10.

Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression

Affiliations
Observational Study

Small Dense Low-Density Lipoprotein Cholesterol and Carotid Intimal Medial Thickness Progression

Hiroaki Ikezaki et al. J Atheroscler Thromb. .

Abstract

Aim: The association between small dense low-density lipoprotein cholesterol (sdLDL-C) levels and carotid intimal medial thickness (cIMT) progression has not been evaluated fully. We assessed specialized lipoproteins, including sdLDL-C, with regard to cIMT progression in a prospective observational study in Japan.

Methods: Plasma total cholesterol, direct LDL-C, sdLDL-C, LDL-triglycerides (LDL-TG), high-density lipoprotein cholesterol (HDL-C), HDL2-C, HDL3-C, triglycerides, Lp(a), and adiponectin were measured in 2,030 men and women (median age 59 years, free of cardiovascular disease (CVD) and off cholesterol lowering medication). At both baseline and after a five-year follow-up, cIMT was assessed. Univariate, multivariate regression, and least square analyses were performed to examine the relationships between direct LDL-C, sdLDL-C, and other lipoproteins with cIMT progression.

Results: The median cIMT at baseline was 0.63 mm and five-year progression was 0.18 mm. After adjustment for standard CVD risk factors, including age, gender, systolic blood pressure, total cholesterol, HDL-C, smoking, diabetes, and hypertension treatment, only direct LDL-C, sdLDL-C, and the sdLDL-C/LDL-C ratio were associated with cIMT progression. Even in subjects with direct LDL-C <100 mg/dL, who were considered at low CVD risk, elevated sdLDL-C were associated with cIMT progression (P for trend=0.009) in a model with established CVD risk factors, although the sdLDL-C/LDL-C ratio did not. Those correlations did not change by including triglycerides as a controlling factor or excluding premenopausal women from the analyzed population.

Conclusions: Small dense LDL-C has a stronger relationship with cIMT progression than LDL-C does; therefore, measuring sdLDL-C may allow for the formulation of optimal therapy for CVD prevention.

Keywords: Atherosclerosis; Cardiovascular diseases; Carotid intimal medial thickness; Small dense LDL cholesterol.

PubMed Disclaimer

Conflict of interest statement

The authors have nothing to declare with regard to conflict of interest.

Figures

Supplementary Fig. 1.
Supplementary Fig. 1.
Correlations between sdLDL-C and other lipoproteins and hsCRP This figure shows scatter plots between sdLDL-C and other lipoproteins and hsCRP. According to Spearman's r values, positive correlations between sdLDL-C were found in order direct LDL-C, triglycerides, non-HDL-C, LDL-TG, large buoyant LDL-C, calculated LDL-C, total cholesterol, and hsCRP. HDL-C, HDL2-C, HDL3-C, adiponectin, and Lp(a) showed negative correlations between sdLDL-C. sdLDL-C, small dense low-density lipoprotein cholesterol; hsCRP, high sensitivity C reactive protein; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-TG, low-density lipoprotein triglycerides; Lp(a), lipoprotein(a).
Supplementary Fig. 1.
Supplementary Fig. 1.
Correlations between sdLDL-C and other lipoproteins and hsCRP This figure shows scatter plots between sdLDL-C and other lipoproteins and hsCRP. According to Spearman's r values, positive correlations between sdLDL-C were found in order direct LDL-C, triglycerides, non-HDL-C, LDL-TG, large buoyant LDL-C, calculated LDL-C, total cholesterol, and hsCRP. HDL-C, HDL2-C, HDL3-C, adiponectin, and Lp(a) showed negative correlations between sdLDL-C. sdLDL-C, small dense low-density lipoprotein cholesterol; hsCRP, high sensitivity C reactive protein; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-TG, low-density lipoprotein triglycerides; Lp(a), lipoprotein(a).
Supplementary Fig. 1.
Supplementary Fig. 1.
Correlations between sdLDL-C and other lipoproteins and hsCRP This figure shows scatter plots between sdLDL-C and other lipoproteins and hsCRP. According to Spearman's r values, positive correlations between sdLDL-C were found in order direct LDL-C, triglycerides, non-HDL-C, LDL-TG, large buoyant LDL-C, calculated LDL-C, total cholesterol, and hsCRP. HDL-C, HDL2-C, HDL3-C, adiponectin, and Lp(a) showed negative correlations between sdLDL-C. sdLDL-C, small dense low-density lipoprotein cholesterol; hsCRP, high sensitivity C reactive protein; LDL-C, low-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-TG, low-density lipoprotein triglycerides; Lp(a), lipoprotein(a).
Fig. 1.
Fig. 1.
Relationship between cIMT progression and serum sdLDL-C levels This figure shows cIMT progression levels by sdLDL-C quartiles and LDL-C levels. Subjects were divided into a low LDL-C group (LDL-C ≤ 100 mg/dL) and a high LDL-C group (LDL-C > 100 mg/dL); they were then stratified into four groups according to sdLDL-C quartiles. cIMT levels were adjusted for standard CVD risk factors using least square methods. Jonckheere-Terpstra trend tests were performed to assess the associations between mean cIMT progressions and sdLDL-C quartiles. Mean cIMT progressions in both the low and high LDL-C groups significantly increased in accordance with higher sdLDL-C quartiles (P for trend < 0.01 and < 0.001, respectively). Among the low LDL-C group, individuals with the highest sdLDL-C quartile had significantly increased cIMT levels than those with the lowest sdLDL-C quartile (P < 0.05), but this was not the case for those with 2nd and 3rd sdLDL-C quartiles. Among the high LDL-C group, individuals with the highest sdLDL-C quartile had significantly increased cIMT levels than those with all other sdLDL-C quartiles (all P < 0.05). Individuals with the highest sdLDL-C quartile in the high LDL-C group had significantly increased cIMT levels than those with all other groups (all P < 0.05). cIMT, carotid intimal medial thickness; sdLDL-C, small dense low-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; CVD, cardiovascular disease.
Fig. 2.
Fig. 2.
Relationship between cIMT progression and sdLDL-C/LDL-C ratios This figure shows cIMT progression levels by sdLDL-C/LDL-C ratio quartiles and LDL-C levels. Subjects were divided to a low LDL-C group (LDL-C ≤ 100 mg/dL) and a high LDL-C group (LDL-C > 100 mg/dL); they were then stratified into four groups according to sdLDL-C/LDL-C ratio quartiles. cIMT levels were adjusted for standard CVD risk factors using least square methods. Jonckheere-Terpstra trend tests were performed to assess the associations between mean cIMT progressions and sdLDL-C quartiles. Mean cIMT progression significantly increased in accordance with higher sdLDL-C/LDL-C ratio quartiles only in the high LDL-C group (P for trend < 0.001); however, there was no significant association between sdLDL-C/LDL-C ratio and cIMT progression in the low LDL-C group. Individuals with the highest sdLDL-C/LDL-C ratio quartile in the high LDL-C group had significant increased cIMT levels than those with all other groups (all P < 0.05). cIMT, carotid intimal medial thickness; sdLDL-C, small dense low-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; CVD, cardiovascular disease.

Similar articles

Cited by

References

    1. Global Health Estimates 2016: Deaths by Cause, Age, Sex, by Country and by Region, 2000–2016. Geneva, World Health Organization; 2018
    1. Goff DC, Jr, Lloyd-Jones DM, Bannett G, Coady S, D'Agostino RB, Sr, Gibbons R, Greenland P, Lackland DT, Levy D, O'Donnell CJ, Robinson JG, Schwartz JS, Shero ST, Smith SC, Jr, Sorlie P, Stone NJ, Wilson PW, American College of Cardiology/American Heart Association Task Force on Practice Guidelines AHA/ACC guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol, 2014; 63: 2935-2959 - PMC - PubMed
    1. Lloyd-Jones DM, Morris PB, Ballantyne CM, Birtcher KK, Daly DD, Jr., DePalma SM, Minissian MB, Orringer CE, Smith SC., Jr. 2017 Focused Update of the 2016 ACC Expert Consensus Decision Pathway on the Role of Non-Statin Therapies for LDL-Cholesterol Lowering in the Management of Atherosclerotic Cardiovascular Disease Risk: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways. J Am Coll Cardiol, 2017; 70: 1785-1822 - PubMed
    1. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem, 1972; 18: 499-502 - PubMed
    1. Martin SS, Blaha MJ, Elshazly MB, Toth PP, Kwiterovich PO, Blumenthal RS, Jones SR. Comparison of a novel method vs the Friedewald equation for estimating low-density lipoprotein cholesterol levels from the standard lipid profile. JAMA, 2013; 310: 2061-2068 - PMC - PubMed

Publication types

MeSH terms